CANC
Tema Oncology ETF
1 year +30.4%Assets$202.58MTema ETFs
Fee0.78%a year
Yield0.1%
This year+14.7%
5 years–a year on average
Components58top 10: 43%
Returns
This year
+14.7%
1 year
+30.4%
3 years, yearly
+20.6%
5 years, yearly
–
10 years, yearly
–
The fund's own total return. Volatility 20.5% over one year, 20.0% over three; Sharpe ratio over three years 0.92.
Sectors
Healthcare100.0%
Regions
North America84.0%
Europe Developed10.6%
United Kingdom2.3%
Asia Emerging1.8%
Asset classes
Stock US84.4%
Stock non-US14.2%
Cash0.6%
About the fund
- Issuer
- Tema ETFs
- Since
- 2023-08-14
- Listed on
- NASDAQ
- ISIN
- US87975E7013
- Turnover
- 0% a year
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
From the market data provider's fund data, read 2026-10-20. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.